NEW YORK (GenomeWeb News) – Promega and GeneCopoeia have entered into an agreement to pair Promega’s HaloTag protein fusion technology with GeneCopoeia’s human and mouse open reading frame OmicsLink sequences, Promega announced today.
The alliance will enable the companies to provide customers with a set of tagged expression-ready ORF clones that can be employed in proteomics and other research. Specifically, HaloTags, Promega’s multi-functional protein tags, are used to covalently tag proteins with synthetic ligands — for instance fluorophores — so that they can be detected, imaged, or immobilized.
For its part, GeneCopoeia has developed 20,000 human and 15,000 mouse ORF clones from sequence-validated full-length cDNA clones and high-fidelity cloning of tissue cDNA libraries.
“HaloTag complements our collections of genome-wide OmicsLink full-length cDNA clones from human, mouse, and other species,” GeneCopoeia Executive Vice President Sun Lu said in a statement.
Financial terms of the agreement were not disclosed.